UNSPSC 51263140: Celiprolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C20H33N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DRB57K47QC, chemically known as urea, n-(3-acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-n,n-diethyl- but generally known as celiprolol, which bears US NIH Compound Identifier 2663. European Medicines Agency schedules Celiprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07436MIG.

UNSPSC 51263140 Celiprolol is a Commodity code that nominally identifies a specific beta-blocker pharmaceutical, but the recent state and local opportunities posted under this code show no procurement of celiprolol itself. Instead, Seminole County, Florida has tagged a procurement for naloxone and drug deactivation systems under this code — a clear mismatch between the code's pharmaceutical scope and the actual goods being solicited. The code shows minimal relevant recent activity tied to its intended commodity classification.

Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, at 2:00 pm. Vendors must include all shipping and delivery costs in their proposals, comply with drug-free workplace certification and E-Verify requirements, maintain workers' compensation and commercial general liability insurance, and accept a three-month probationary period. The contract carries a two-year initial term with a one-year renewal option and is potentially funded through FEMA, introducing additional federal compliance obligations. Beyond this single opportunity, the code shows no broader pattern of state and local purchasing activity, and the mismatch between the code label and the naloxone procurement suggests either a data-entry error or tagging anomaly rather than a genuine market signal for celiprolol procurement at the state and local level.